Mersana TherapeuticsMRSN
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)
Mersana TherapeuticsMRSN
0
0
(0%)
財務數據
損益表
- 0.11
- 0.08
- 0.11
- 0.09
- 0.02
- 0.13
- 0.16
- 0.03
- 0.03
- 0.11
- 36.55
- -27.75
- 39.01
- -13.61
- -75.20
- 449.41
- 29.87
- -83.17
- 10.97
- 260.24
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 11,009 | 3,056 | 2,754 | 16,361 | 12,598 | 2,293 | 9,245 | 10,701 | 7,698 | 10,654 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 11,009 | 3,056 | 2,754 | 16,361 | 12,598 | 2,293 | 9,245 | 10,701 | 7,698 | 10,654 |
營業費用 | 18,676 | 27,573 | - | - | - | - | 30,246 | 32,128 | 51,639 | 67,155 |
研發費用 | 12,182 | 16,218 | 18,341 | 22,286 | 14,803 | 17,245 | 18,686 | 21,495 | 30,531 | 48,968 |
推銷及管理費用 | 6,303 | 7,415 | 8,925 | 8,886 | 9,864 | 10,503 | 11,560 | 10,134 | 12,894 | 18,187 |
非經常性項目費用 | 191 | 3,940 | - | - | - | - | - | 499 | 8,214 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -7,667 | -24,517 | -24,512 | -14,811 | -12,069 | -25,455 | -21,001 | -21,427 | -43,941 | -56,501 |
其他收入及費用 | 516 | 895 | 1,164 | 1,597 | 1,972 | 2,170 | 2,697 | 2,931 | 3,302 | 3,219 |
利息費用 | 394 | 674 | 775 | 903 | 986 | 983 | 1,002 | 1,048 | 1,017 | 1,025 |
稅前純益 | -7,545 | -24,296 | -24,123 | -14,117 | -11,083 | -24,268 | -19,306 | -19,544 | -41,656 | -54,307 |
所得稅 | - | - | - | - | 418 | - | - | - | - | - |
稅後純益 | -7,545 | -24,296 | -24,123 | -14,117 | -11,501 | -24,268 | -19,306 | -19,544 | -41,656 | -54,307 |
基本每股稅後盈餘(元) | -1.51 | -0.19 | -0.19 | -0.11 | -0.09 | -0.20 | -0.16 | -0.16 | -0.35 | -0.47 |
稀釋每股稅後盈餘(元) | -1.50 | -0.19 | -0.19 | -0.11 | -0.09 | -0.20 | -0.16 | -0.15 | -0.34 | -0.47 |
基本平均股數(千股) | 4992.00 | 124669.00 | 124466.00 | 123558.00 | 122722.00 | 122440.00 | 121424.00 | 120614.00 | 120521.00 | 115608.00 |
稀釋平均股數(千股) | 4992.00 | 124669.00 | 124466.00 | 123558.00 | 122722.00 | 122440.00 | 121424.00 | 120614.00 | 120521.00 | 115608.00 |
還原基本每股稅後盈餘(元) | -1.51 | -4.87 | -4.75 | -2.75 | -2.34 | -5.00 | -4.00 | -4.00 | -8.75 | -11.75 |
還原稀釋每股稅後盈餘(元) | -1.50 | -4.87 | -4.75 | -2.73 | -2.34 | -5.00 | -4.00 | -3.75 | -8.50 | -11.75 |
還原基本平均股數(千股) | 4,992 | 4,986 | 4,978 | 4,942 | 4,908 | 4,897 | 4,856 | 4,824 | 4,820 | 4,624 |
還原稀釋平均股數(千股) | 4,992 | 4,986 | 4,978 | 4,942 | 4,908 | 4,897 | 4,856 | 4,824 | 4,820 | 4,624 |
EBITDA(千元) | -7,068 | -23,335 | -23,172 | -13,396 | -10,628 | -24,167 | -18,998 | -18,379 | -41,260 | -54,738 |